CLINICAL_TRIALS
trial_result
· 2022-03-18
Clinical Trial Update: Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India [Phase 4]
Summary
Open-label, flexible-dose Phase 4 trial of vortioxetine in India for major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED